Press Releases

Date	Title	PDF Version
Dec 06, 2009	Soliris(R) Reduced Hemolysis, Decreased Transfusion Requirements and Improved Fatigue in Patients with PNH and Bone Marrow Insufficiency Disorders
Dec 06, 2009	Researchers Report Clinical Association Between Type II PNH Cells and Thrombocytopenia
Dec 05, 2009	Long-Term Soliris(R) Treatment Resulted in Sustained Reduction in Hemolysis and Improved Kidney Function in Japanese Patients with PNH
Dec 02, 2009	Alexion Reports Progress on Commissioning of Rhode Island Manufacturing Facility as Second Source of Supply
Dec 01, 2009	Alexion Appoints William R. Keller to its Board of Directors
Nov 11, 2009	Alexion to Present at Lazard Capital Markets 6th Annual Healthcare Conference
Nov 10, 2009	Researchers to Present Additional Data on Soliris(R) (eculizumab) for the Treatment of Patients With PNH at the ASH Annual Meeting
Nov 05, 2009	Alexion to Present at Credit Suisse's 2009 Healthcare Conference
Oct 28, 2009	Alexion to Present at the Oppenheimer 20th Annual Healthcare Conference
Oct 22, 2009	Alexion Reports Third Quarter 2009 Results

Search